Emergent Biosolutions
Clinical trials sponsored by Emergent Biosolutions, explained in plain language.
-
Scientists Fine-Tune lifesaving botulism treatment for kids
Disease control ENROLLING_BY_INVITATIONThis study aims to verify that the current recommended dose of a botulism antitoxin (BAT) is correct for children. It involves up to 10 children under 12 years old who are receiving the antitoxin for a confirmed or suspected botulism exposure. Researchers will take a few small bl…
Phase: PHASE4 • Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Treatment tested for dangerous smallpox vaccine side effects
Disease control ENROLLING_BY_INVITATIONThis study is checking how well a treatment called VIGIV works for people who develop serious complications after getting the smallpox vaccine. It will follow 100 patients who have severe skin reactions or infections caused by the vaccine virus. The main goal is to see if the tre…
Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC